Shares of Moderna Surged Thanks to Vaccine Trial
An American company from Massachusetts reported the news that helped to boost its shares. According to Moderna, early-stage human trial for a coronavirus vaccine produced COVID-19 antibodies in all participants. Notably, 45 people took part in this process. The company’s shares jumped more than 17%. Participants received two doses of the potential vaccine via intramuscular …
Shares of Moderna Surged Thanks to Vaccine Trial Read More »